Evidence map›Paper›PMID 42189711›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Mechanically Regulated Nanozymes for Remote Metabolic Reprogramming and Precise Cancer Therapy.

Fangman Chen, Xiaochun Xie, Hanyao Huang, Ka Hong Wong, Jiying Liu, Hui Fang, Shaowen Wang, Jianfang Cao, Yu Tao, Mingqiang Li and 4 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Fangman ChenCancer Centre and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, China.
Xiaochun XieState Key Laboratory of Oral Diseases and National Clinical Research Center For Oral Diseases and Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Hanyao HuangState Key Laboratory of Oral Diseases and National Clinical Research Center For Oral Diseases and Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Ka Hong WongState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, China.ORCID 0009-0004-2714-7376
Jiying LiuDepartment of Chemistry, University of Michigan, Ann Arbor, USA.
Hui FangSchool of Medicine, South China University of Technology, Guangzhou, China.
Shaowen WangSchool of Medicine, South China University of Technology, Guangzhou, China.
Jianfang CaoState Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, Dalian, China.
Yu TaoLaboratory of Biomaterials and Translational Medicine, Department of Ultrasound, Center For Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Mingqiang LiLaboratory of Biomaterials and Translational Medicine, Department of Ultrasound, Center For Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-5178-4138
Chao YangDepartment of Orthopedics, Center For Orthopedic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
Wen SunState Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, Dalian, China.ORCID 0000-0003-4316-5350
Dan ShaoState Key Laboratory of Oral Diseases and National Clinical Research Center For Oral Diseases and Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Yunlu DaiCancer Centre and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR, China.ORCID 0000-0003-4023-7320

Funding

Guangdong Provincial Applied Science and Technology Research and Development Program 2024A1515011140International Science &Technology Cooperation Program of Hainan Province GHYF2025024National Natural Science Foundation of China 32571533National Natural Science Foundation of China 82572452Science and Technology Development Fund, Macau SAR 0002/2025/ASJScience and Technology Development Fund, Macau SAR 0009/2022/AKPScience and Technology Development Fund, Macau SAR 0133/2022/A3University of Macau and the University of Macau Development Foundation (UMDF) GRG2024-00095University of Macau and the University of Macau Development Foundation (UMDF) MYRG-GRG2023-00013
6 · The paper itself

Abstract

Mechanoenzymes, featuring catalytic activity controlled by mechanical stimuli, play key roles in maintaining metabolic order and cellular homeostasis. However, artificial nanozymes with strict spatiotemporal regulation are still rare, limiting their effectiveness in complex biological environments. Here, we introduce a mechanically regulated nanozyme (MRNZ) by integrating mechano-responsive ferrocene (Fc) units into a flexible framework. Similar to natural enzymatic activation, acoustic shear forces cause sub-nanostructural transformations of Fc units, leading to decreased electron density and reduced steric hindrance at Fe active sites, reinforcing metabolic peroxidase (POD)-like activity. This mechanical activation enables precise modulation of metabolic reprogramming by controlled generation of low-dose hydroxyl radicals (•OH) as second messengers, improving stem cells resilience to oxidative stress for safer and more effective therapeutic interventions. Using this mechanically regulated method, we encapsulated glucose oxidase (GOx) inside hollow MRNZ to create a multienzyme regulated nanoreactor (MRNZ@GOx) that orchestrates a cascade GOx-POD reaction under ultrasound stimulation. Such a cascade reactive oxygen species generation in tumor microenvironments potentiates chemodynamic therapy combined with immune activation. Our work introduces a mechanically responsive strategy for regulating nanozyme activity, expanding the horizons of next-generation remote and smart catalytic technologies for precise disease treatments.

Indexed as

Glucose OxidaseNanostructuresNeoplasmsAnimalsFerrous CompoundsHumansMetabolic ReprogrammingMetallocenesReactive Oxygen SpeciesferroceneFerrous CompoundsGlucose OxidaseMetallocenesReactive Oxygen Speciescascade catalysismechanical forcemechanical regulationnanozymetumor therapy

Identifiers

PMID42189711
PMCPMC13383197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.